NEW YORK – Enzo Biochem reported after the close of the market on Tuesday that its fourth quarter revenues fell nearly 7 percent year over year, due to a 26 percent decrease in revenues from its life sciences business unit.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.